FDA Approves Etex Bone Substitute, CarriGen 03/15/2010Posted by Morse, Barnes-Brown Pendleton in Client News.
Tags: bone substitute, Etex, FDA
MBBP client Etex Corporation, a Cambridge based biomaterials company, reports the FDA has approved its bone substitute product, CarriGen, which it will begin selling immediately. The product, which is a viscous putty made of nanocrystalline calcium phosphate, is a porous bone graft substitute that sets hard on implantation, filling the defect area and is intended to be used to fill holes in the bones of the pelvis, extremities and spine. The artificial bone material creates a scaffold-like structure comparatively as strong as natural bone.
For more information on CarriGen, please visit Etex Corporation.